0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Vancomycin Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-20N7760
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Vancomycin Market Insights and Forecast to 2028
BUY CHAPTERS

Global Vancomycin Market Research Report 2025

Code: QYRE-Auto-20N7760
Report
July 2025
Pages:127
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Vancomycin Market

The global market for Vancomycin was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Vancomycin is an effective and safe antibiotic in the treatment of severe infections caused by methicillin-resistant staphylococcus aureus, methicillin-resistant coagulase-negative staphylococcus and enterococcus, including sepsis, pulmonary infection and skin and soft tissue infection.
North American market for Vancomycin is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Vancomycin is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Vancomycin include Pfizer, Eli Lilly and Company, CJ CheilJedang, Xellia Pharmaceuticals ApS, VIANEX, Alchemia Limited, Alvogen, Aphios Corporation, Cellceutix Corporation, Enanta Pharmaceuticals, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Vancomycin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Vancomycin.
The Vancomycin market size, estimations, and forecasts are provided in terms of sales volume (KG) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Vancomycin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Vancomycin manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Vancomycin Market Report

Report Metric Details
Report Name Vancomycin Market
Segment by Type
  • Daptomycin
  • Linezolid
  • Quinupristin
  • Ampicillin
  • Chloramphenicol
  • Others
Segment by Application
  • Sepsis
  • Lung Infection
  • Skin Soft Tissue Infection
  • Colitis & Intestinal Inflammation
  • To Prevent Infection
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Pfizer, Eli Lilly and Company, CJ CheilJedang, Xellia Pharmaceuticals ApS, VIANEX, Alchemia Limited, Alvogen, Aphios Corporation, Cellceutix Corporation, Enanta Pharmaceuticals, Helix BioMedix, LegoChem Biosciences, Lytix Biopharma, MGB Biopharma Limited, Microbiotix., MicuRx Pharmaceuticals, Nabriva Therapeutics, NovaBay Pharmaceuticals, NovoBiotic Pharmaceuticals, Oragenics, Sealife Pharma, Taiwan Zhengde Pharmaceutical, Zhejiang Pharmaceutical, Zhejiang Haizheng Pharmaceutical, North China Pharmaceutical, Shenwei Pharmaceutical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Vancomycin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Vancomycin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Vancomycin Market report?

Ans: The main players in the Vancomycin Market are Pfizer, Eli Lilly and Company, CJ CheilJedang, Xellia Pharmaceuticals ApS, VIANEX, Alchemia Limited, Alvogen, Aphios Corporation, Cellceutix Corporation, Enanta Pharmaceuticals, Helix BioMedix, LegoChem Biosciences, Lytix Biopharma, MGB Biopharma Limited, Microbiotix., MicuRx Pharmaceuticals, Nabriva Therapeutics, NovaBay Pharmaceuticals, NovoBiotic Pharmaceuticals, Oragenics, Sealife Pharma, Taiwan Zhengde Pharmaceutical, Zhejiang Pharmaceutical, Zhejiang Haizheng Pharmaceutical, North China Pharmaceutical, Shenwei Pharmaceutical

What are the Application segmentation covered in the Vancomycin Market report?

Ans: The Applications covered in the Vancomycin Market report are Sepsis, Lung Infection, Skin Soft Tissue Infection, Colitis & Intestinal Inflammation, To Prevent Infection

What are the Type segmentation covered in the Vancomycin Market report?

Ans: The Types covered in the Vancomycin Market report are Daptomycin, Linezolid, Quinupristin, Ampicillin, Chloramphenicol, Others

1 Vancomycin Market Overview
1.1 Product Definition
1.2 Vancomycin by Type
1.2.1 Global Vancomycin Market Value Comparison by Type (2024 VS 2031)
1.2.2 Daptomycin
1.2.3 Linezolid
1.2.4 Quinupristin
1.2.5 Ampicillin
1.2.6 Chloramphenicol
1.2.7 Others
1.3 Vancomycin by Application
1.3.1 Global Vancomycin Market Value by Application (2024 VS 2031)
1.3.2 Sepsis
1.3.3 Lung Infection
1.3.4 Skin Soft Tissue Infection
1.3.5 Colitis & Intestinal Inflammation
1.3.6 To Prevent Infection
1.4 Global Vancomycin Market Size Estimates and Forecasts
1.4.1 Global Vancomycin Revenue 2020-2031
1.4.2 Global Vancomycin Sales 2020-2031
1.4.3 Global Vancomycin Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Vancomycin Market Competition by Manufacturers
2.1 Global Vancomycin Sales Market Share by Manufacturers (2020-2025)
2.2 Global Vancomycin Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Vancomycin Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Vancomycin, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Vancomycin, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Vancomycin, Product Type & Application
2.7 Global Key Manufacturers of Vancomycin, Date of Enter into This Industry
2.8 Global Vancomycin Market Competitive Situation and Trends
2.8.1 Global Vancomycin Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Vancomycin Players Market Share by Revenue
2.8.3 Global Vancomycin Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Vancomycin Market Scenario by Region
3.1 Global Vancomycin Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Vancomycin Sales by Region: 2020-2031
3.2.1 Global Vancomycin Sales by Region: 2020-2025
3.2.2 Global Vancomycin Sales by Region: 2026-2031
3.3 Global Vancomycin Revenue by Region: 2020-2031
3.3.1 Global Vancomycin Revenue by Region: 2020-2025
3.3.2 Global Vancomycin Revenue by Region: 2026-2031
3.4 North America Vancomycin Market Facts & Figures by Country
3.4.1 North America Vancomycin Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Vancomycin Sales by Country (2020-2031)
3.4.3 North America Vancomycin Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Vancomycin Market Facts & Figures by Country
3.5.1 Europe Vancomycin Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Vancomycin Sales by Country (2020-2031)
3.5.3 Europe Vancomycin Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Vancomycin Market Facts & Figures by Region
3.6.1 Asia Pacific Vancomycin Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Vancomycin Sales by Region (2020-2031)
3.6.3 Asia Pacific Vancomycin Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Vancomycin Market Facts & Figures by Country
3.7.1 Latin America Vancomycin Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Vancomycin Sales by Country (2020-2031)
3.7.3 Latin America Vancomycin Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Vancomycin Market Facts & Figures by Country
3.8.1 Middle East and Africa Vancomycin Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Vancomycin Sales by Country (2020-2031)
3.8.3 Middle East and Africa Vancomycin Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Vancomycin Sales by Type (2020-2031)
4.1.1 Global Vancomycin Sales by Type (2020-2025)
4.1.2 Global Vancomycin Sales by Type (2026-2031)
4.1.3 Global Vancomycin Sales Market Share by Type (2020-2031)
4.2 Global Vancomycin Revenue by Type (2020-2031)
4.2.1 Global Vancomycin Revenue by Type (2020-2025)
4.2.2 Global Vancomycin Revenue by Type (2026-2031)
4.2.3 Global Vancomycin Revenue Market Share by Type (2020-2031)
4.3 Global Vancomycin Price by Type (2020-2031)
5 Segment by Application
5.1 Global Vancomycin Sales by Application (2020-2031)
5.1.1 Global Vancomycin Sales by Application (2020-2025)
5.1.2 Global Vancomycin Sales by Application (2026-2031)
5.1.3 Global Vancomycin Sales Market Share by Application (2020-2031)
5.2 Global Vancomycin Revenue by Application (2020-2031)
5.2.1 Global Vancomycin Revenue by Application (2020-2025)
5.2.2 Global Vancomycin Revenue by Application (2026-2031)
5.2.3 Global Vancomycin Revenue Market Share by Application (2020-2031)
5.3 Global Vancomycin Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Company Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer Vancomycin Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Pfizer Vancomycin Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 Eli Lilly and Company
6.2.1 Eli Lilly and Company Company Information
6.2.2 Eli Lilly and Company Description and Business Overview
6.2.3 Eli Lilly and Company Vancomycin Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Eli Lilly and Company Vancomycin Product Portfolio
6.2.5 Eli Lilly and Company Recent Developments/Updates
6.3 CJ CheilJedang
6.3.1 CJ CheilJedang Company Information
6.3.2 CJ CheilJedang Description and Business Overview
6.3.3 CJ CheilJedang Vancomycin Sales, Revenue and Gross Margin (2020-2025)
6.3.4 CJ CheilJedang Vancomycin Product Portfolio
6.3.5 CJ CheilJedang Recent Developments/Updates
6.4 Xellia Pharmaceuticals ApS
6.4.1 Xellia Pharmaceuticals ApS Company Information
6.4.2 Xellia Pharmaceuticals ApS Description and Business Overview
6.4.3 Xellia Pharmaceuticals ApS Vancomycin Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Xellia Pharmaceuticals ApS Vancomycin Product Portfolio
6.4.5 Xellia Pharmaceuticals ApS Recent Developments/Updates
6.5 VIANEX
6.5.1 VIANEX Company Information
6.5.2 VIANEX Description and Business Overview
6.5.3 VIANEX Vancomycin Sales, Revenue and Gross Margin (2020-2025)
6.5.4 VIANEX Vancomycin Product Portfolio
6.5.5 VIANEX Recent Developments/Updates
6.6 Alchemia Limited
6.6.1 Alchemia Limited Company Information
6.6.2 Alchemia Limited Description and Business Overview
6.6.3 Alchemia Limited Vancomycin Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Alchemia Limited Vancomycin Product Portfolio
6.6.5 Alchemia Limited Recent Developments/Updates
6.7 Alvogen
6.7.1 Alvogen Company Information
6.7.2 Alvogen Description and Business Overview
6.7.3 Alvogen Vancomycin Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Alvogen Vancomycin Product Portfolio
6.7.5 Alvogen Recent Developments/Updates
6.8 Aphios Corporation
6.8.1 Aphios Corporation Company Information
6.8.2 Aphios Corporation Description and Business Overview
6.8.3 Aphios Corporation Vancomycin Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Aphios Corporation Vancomycin Product Portfolio
6.8.5 Aphios Corporation Recent Developments/Updates
6.9 Cellceutix Corporation
6.9.1 Cellceutix Corporation Company Information
6.9.2 Cellceutix Corporation Description and Business Overview
6.9.3 Cellceutix Corporation Vancomycin Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Cellceutix Corporation Vancomycin Product Portfolio
6.9.5 Cellceutix Corporation Recent Developments/Updates
6.10 Enanta Pharmaceuticals
6.10.1 Enanta Pharmaceuticals Company Information
6.10.2 Enanta Pharmaceuticals Description and Business Overview
6.10.3 Enanta Pharmaceuticals Vancomycin Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Enanta Pharmaceuticals Vancomycin Product Portfolio
6.10.5 Enanta Pharmaceuticals Recent Developments/Updates
6.11 Helix BioMedix
6.11.1 Helix BioMedix Company Information
6.11.2 Helix BioMedix Description and Business Overview
6.11.3 Helix BioMedix Vancomycin Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Helix BioMedix Vancomycin Product Portfolio
6.11.5 Helix BioMedix Recent Developments/Updates
6.12 LegoChem Biosciences
6.12.1 LegoChem Biosciences Company Information
6.12.2 LegoChem Biosciences Description and Business Overview
6.12.3 LegoChem Biosciences Vancomycin Sales, Revenue and Gross Margin (2020-2025)
6.12.4 LegoChem Biosciences Vancomycin Product Portfolio
6.12.5 LegoChem Biosciences Recent Developments/Updates
6.13 Lytix Biopharma
6.13.1 Lytix Biopharma Company Information
6.13.2 Lytix Biopharma Description and Business Overview
6.13.3 Lytix Biopharma Vancomycin Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Lytix Biopharma Vancomycin Product Portfolio
6.13.5 Lytix Biopharma Recent Developments/Updates
6.14 MGB Biopharma Limited
6.14.1 MGB Biopharma Limited Company Information
6.14.2 MGB Biopharma Limited Description and Business Overview
6.14.3 MGB Biopharma Limited Vancomycin Sales, Revenue and Gross Margin (2020-2025)
6.14.4 MGB Biopharma Limited Vancomycin Product Portfolio
6.14.5 MGB Biopharma Limited Recent Developments/Updates
6.15 Microbiotix.
6.15.1 Microbiotix. Company Information
6.15.2 Microbiotix. Description and Business Overview
6.15.3 Microbiotix. Vancomycin Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Microbiotix. Vancomycin Product Portfolio
6.15.5 Microbiotix. Recent Developments/Updates
6.16 MicuRx Pharmaceuticals
6.16.1 MicuRx Pharmaceuticals Company Information
6.16.2 MicuRx Pharmaceuticals Description and Business Overview
6.16.3 MicuRx Pharmaceuticals Vancomycin Sales, Revenue and Gross Margin (2020-2025)
6.16.4 MicuRx Pharmaceuticals Vancomycin Product Portfolio
6.16.5 MicuRx Pharmaceuticals Recent Developments/Updates
6.17 Nabriva Therapeutics
6.17.1 Nabriva Therapeutics Company Information
6.17.2 Nabriva Therapeutics Description and Business Overview
6.17.3 Nabriva Therapeutics Vancomycin Sales, Revenue and Gross Margin (2020-2025)
6.17.4 Nabriva Therapeutics Vancomycin Product Portfolio
6.17.5 Nabriva Therapeutics Recent Developments/Updates
6.18 NovaBay Pharmaceuticals
6.18.1 NovaBay Pharmaceuticals Company Information
6.18.2 NovaBay Pharmaceuticals Description and Business Overview
6.18.3 NovaBay Pharmaceuticals Vancomycin Sales, Revenue and Gross Margin (2020-2025)
6.18.4 NovaBay Pharmaceuticals Vancomycin Product Portfolio
6.18.5 NovaBay Pharmaceuticals Recent Developments/Updates
6.19 NovoBiotic Pharmaceuticals
6.19.1 NovoBiotic Pharmaceuticals Company Information
6.19.2 NovoBiotic Pharmaceuticals Description and Business Overview
6.19.3 NovoBiotic Pharmaceuticals Vancomycin Sales, Revenue and Gross Margin (2020-2025)
6.19.4 NovoBiotic Pharmaceuticals Vancomycin Product Portfolio
6.19.5 NovoBiotic Pharmaceuticals Recent Developments/Updates
6.20 Oragenics
6.20.1 Oragenics Company Information
6.20.2 Oragenics Description and Business Overview
6.20.3 Oragenics Vancomycin Sales, Revenue and Gross Margin (2020-2025)
6.20.4 Oragenics Vancomycin Product Portfolio
6.20.5 Oragenics Recent Developments/Updates
6.21 Sealife Pharma
6.21.1 Sealife Pharma Company Information
6.21.2 Sealife Pharma Description and Business Overview
6.21.3 Sealife Pharma Vancomycin Sales, Revenue and Gross Margin (2020-2025)
6.21.4 Sealife Pharma Vancomycin Product Portfolio
6.21.5 Sealife Pharma Recent Developments/Updates
6.22 Taiwan Zhengde Pharmaceutical
6.22.1 Taiwan Zhengde Pharmaceutical Company Information
6.22.2 Taiwan Zhengde Pharmaceutical Description and Business Overview
6.22.3 Taiwan Zhengde Pharmaceutical Vancomycin Sales, Revenue and Gross Margin (2020-2025)
6.22.4 Taiwan Zhengde Pharmaceutical Vancomycin Product Portfolio
6.22.5 Taiwan Zhengde Pharmaceutical Recent Developments/Updates
6.23 Zhejiang Pharmaceutical
6.23.1 Zhejiang Pharmaceutical Company Information
6.23.2 Zhejiang Pharmaceutical Description and Business Overview
6.23.3 Zhejiang Pharmaceutical Vancomycin Sales, Revenue and Gross Margin (2020-2025)
6.23.4 Zhejiang Pharmaceutical Vancomycin Product Portfolio
6.23.5 Zhejiang Pharmaceutical Recent Developments/Updates
6.24 Zhejiang Haizheng Pharmaceutical
6.24.1 Zhejiang Haizheng Pharmaceutical Company Information
6.24.2 Zhejiang Haizheng Pharmaceutical Description and Business Overview
6.24.3 Zhejiang Haizheng Pharmaceutical Vancomycin Sales, Revenue and Gross Margin (2020-2025)
6.24.4 Zhejiang Haizheng Pharmaceutical Vancomycin Product Portfolio
6.24.5 Zhejiang Haizheng Pharmaceutical Recent Developments/Updates
6.25 North China Pharmaceutical
6.25.1 North China Pharmaceutical Company Information
6.25.2 North China Pharmaceutical Description and Business Overview
6.25.3 North China Pharmaceutical Vancomycin Sales, Revenue and Gross Margin (2020-2025)
6.25.4 North China Pharmaceutical Vancomycin Product Portfolio
6.25.5 North China Pharmaceutical Recent Developments/Updates
6.26 Shenwei Pharmaceutical
6.26.1 Shenwei Pharmaceutical Company Information
6.26.2 Shenwei Pharmaceutical Description and Business Overview
6.26.3 Shenwei Pharmaceutical Vancomycin Sales, Revenue and Gross Margin (2020-2025)
6.26.4 Shenwei Pharmaceutical Vancomycin Product Portfolio
6.26.5 Shenwei Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Vancomycin Industry Chain Analysis
7.2 Vancomycin Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Vancomycin Production Mode & Process Analysis
7.4 Vancomycin Sales and Marketing
7.4.1 Vancomycin Sales Channels
7.4.2 Vancomycin Distributors
7.5 Vancomycin Customer Analysis
8 Vancomycin Market Dynamics
8.1 Vancomycin Industry Trends
8.2 Vancomycin Market Drivers
8.3 Vancomycin Market Challenges
8.4 Vancomycin Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Vancomycin Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Vancomycin Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Vancomycin Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Vancomycin Sales (KG) of Key Manufacturers (2020-2025)
 Table 5. Global Vancomycin Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Vancomycin Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Vancomycin Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Vancomycin Average Price (US$/G) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Vancomycin, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Vancomycin, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Vancomycin, Product Type & Application
 Table 12. Global Key Manufacturers of Vancomycin, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Vancomycin by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Vancomycin as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Vancomycin Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Vancomycin Sales by Region (2020-2025) & (KG)
 Table 18. Global Vancomycin Sales Market Share by Region (2020-2025)
 Table 19. Global Vancomycin Sales by Region (2026-2031) & (KG)
 Table 20. Global Vancomycin Sales Market Share by Region (2026-2031)
 Table 21. Global Vancomycin Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Vancomycin Revenue Market Share by Region (2020-2025)
 Table 23. Global Vancomycin Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Vancomycin Revenue Market Share by Region (2026-2031)
 Table 25. North America Vancomycin Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Vancomycin Sales by Country (2020-2025) & (KG)
 Table 27. North America Vancomycin Sales by Country (2026-2031) & (KG)
 Table 28. North America Vancomycin Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Vancomycin Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Vancomycin Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Vancomycin Sales by Country (2020-2025) & (KG)
 Table 32. Europe Vancomycin Sales by Country (2026-2031) & (KG)
 Table 33. Europe Vancomycin Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Vancomycin Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Vancomycin Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Vancomycin Sales by Region (2020-2025) & (KG)
 Table 37. Asia Pacific Vancomycin Sales by Region (2026-2031) & (KG)
 Table 38. Asia Pacific Vancomycin Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Vancomycin Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Vancomycin Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Vancomycin Sales by Country (2020-2025) & (KG)
 Table 42. Latin America Vancomycin Sales by Country (2026-2031) & (KG)
 Table 43. Latin America Vancomycin Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Vancomycin Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Vancomycin Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Vancomycin Sales by Country (2020-2025) & (KG)
 Table 47. Middle East and Africa Vancomycin Sales by Country (2026-2031) & (KG)
 Table 48. Middle East and Africa Vancomycin Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Vancomycin Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Vancomycin Sales (KG) by Type (2020-2025)
 Table 51. Global Vancomycin Sales (KG) by Type (2026-2031)
 Table 52. Global Vancomycin Sales Market Share by Type (2020-2025)
 Table 53. Global Vancomycin Sales Market Share by Type (2026-2031)
 Table 54. Global Vancomycin Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Vancomycin Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Vancomycin Revenue Market Share by Type (2020-2025)
 Table 57. Global Vancomycin Revenue Market Share by Type (2026-2031)
 Table 58. Global Vancomycin Price (US$/G) by Type (2020-2025)
 Table 59. Global Vancomycin Price (US$/G) by Type (2026-2031)
 Table 60. Global Vancomycin Sales (KG) by Application (2020-2025)
 Table 61. Global Vancomycin Sales (KG) by Application (2026-2031)
 Table 62. Global Vancomycin Sales Market Share by Application (2020-2025)
 Table 63. Global Vancomycin Sales Market Share by Application (2026-2031)
 Table 64. Global Vancomycin Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Vancomycin Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Vancomycin Revenue Market Share by Application (2020-2025)
 Table 67. Global Vancomycin Revenue Market Share by Application (2026-2031)
 Table 68. Global Vancomycin Price (US$/G) by Application (2020-2025)
 Table 69. Global Vancomycin Price (US$/G) by Application (2026-2031)
 Table 70. Pfizer Company Information
 Table 71. Pfizer Description and Business Overview
 Table 72. Pfizer Vancomycin Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2020-2025)
 Table 73. Pfizer Vancomycin Product
 Table 74. Pfizer Recent Developments/Updates
 Table 75. Eli Lilly and Company Company Information
 Table 76. Eli Lilly and Company Description and Business Overview
 Table 77. Eli Lilly and Company Vancomycin Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2020-2025)
 Table 78. Eli Lilly and Company Vancomycin Product
 Table 79. Eli Lilly and Company Recent Developments/Updates
 Table 80. CJ CheilJedang Company Information
 Table 81. CJ CheilJedang Description and Business Overview
 Table 82. CJ CheilJedang Vancomycin Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2020-2025)
 Table 83. CJ CheilJedang Vancomycin Product
 Table 84. CJ CheilJedang Recent Developments/Updates
 Table 85. Xellia Pharmaceuticals ApS Company Information
 Table 86. Xellia Pharmaceuticals ApS Description and Business Overview
 Table 87. Xellia Pharmaceuticals ApS Vancomycin Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2020-2025)
 Table 88. Xellia Pharmaceuticals ApS Vancomycin Product
 Table 89. Xellia Pharmaceuticals ApS Recent Developments/Updates
 Table 90. VIANEX Company Information
 Table 91. VIANEX Description and Business Overview
 Table 92. VIANEX Vancomycin Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2020-2025)
 Table 93. VIANEX Vancomycin Product
 Table 94. VIANEX Recent Developments/Updates
 Table 95. Alchemia Limited Company Information
 Table 96. Alchemia Limited Description and Business Overview
 Table 97. Alchemia Limited Vancomycin Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2020-2025)
 Table 98. Alchemia Limited Vancomycin Product
 Table 99. Alchemia Limited Recent Developments/Updates
 Table 100. Alvogen Company Information
 Table 101. Alvogen Description and Business Overview
 Table 102. Alvogen Vancomycin Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2020-2025)
 Table 103. Alvogen Vancomycin Product
 Table 104. Alvogen Recent Developments/Updates
 Table 105. Aphios Corporation Company Information
 Table 106. Aphios Corporation Description and Business Overview
 Table 107. Aphios Corporation Vancomycin Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2020-2025)
 Table 108. Aphios Corporation Vancomycin Product
 Table 109. Aphios Corporation Recent Developments/Updates
 Table 110. Cellceutix Corporation Company Information
 Table 111. Cellceutix Corporation Description and Business Overview
 Table 112. Cellceutix Corporation Vancomycin Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2020-2025)
 Table 113. Cellceutix Corporation Vancomycin Product
 Table 114. Cellceutix Corporation Recent Developments/Updates
 Table 115. Enanta Pharmaceuticals Company Information
 Table 116. Enanta Pharmaceuticals Description and Business Overview
 Table 117. Enanta Pharmaceuticals Vancomycin Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2020-2025)
 Table 118. Enanta Pharmaceuticals Vancomycin Product
 Table 119. Enanta Pharmaceuticals Recent Developments/Updates
 Table 120. Helix BioMedix Company Information
 Table 121. Helix BioMedix Description and Business Overview
 Table 122. Helix BioMedix Vancomycin Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2020-2025)
 Table 123. Helix BioMedix Vancomycin Product
 Table 124. Helix BioMedix Recent Developments/Updates
 Table 125. LegoChem Biosciences Company Information
 Table 126. LegoChem Biosciences Description and Business Overview
 Table 127. LegoChem Biosciences Vancomycin Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2020-2025)
 Table 128. LegoChem Biosciences Vancomycin Product
 Table 129. LegoChem Biosciences Recent Developments/Updates
 Table 130. Lytix Biopharma Company Information
 Table 131. Lytix Biopharma Description and Business Overview
 Table 132. Lytix Biopharma Vancomycin Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2020-2025)
 Table 133. Lytix Biopharma Vancomycin Product
 Table 134. Lytix Biopharma Recent Developments/Updates
 Table 135. MGB Biopharma Limited Company Information
 Table 136. MGB Biopharma Limited Description and Business Overview
 Table 137. MGB Biopharma Limited Vancomycin Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2020-2025)
 Table 138. MGB Biopharma Limited Vancomycin Product
 Table 139. MGB Biopharma Limited Recent Developments/Updates
 Table 140. Microbiotix. Company Information
 Table 141. Microbiotix. Description and Business Overview
 Table 142. Microbiotix. Vancomycin Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2020-2025)
 Table 143. Microbiotix. Vancomycin Product
 Table 144. Microbiotix. Recent Developments/Updates
 Table 145. MicuRx Pharmaceuticals Company Information
 Table 146. MicuRx Pharmaceuticals Description and Business Overview
 Table 147. MicuRx Pharmaceuticals Vancomycin Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2020-2025)
 Table 148. MicuRx Pharmaceuticals Vancomycin Product
 Table 149. MicuRx Pharmaceuticals Recent Developments/Updates
 Table 150. Nabriva Therapeutics Company Information
 Table 151. Nabriva Therapeutics Description and Business Overview
 Table 152. Nabriva Therapeutics Vancomycin Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2020-2025)
 Table 153. Nabriva Therapeutics Vancomycin Product
 Table 154. Nabriva Therapeutics Recent Developments/Updates
 Table 155. NovaBay Pharmaceuticals Company Information
 Table 156. NovaBay Pharmaceuticals Description and Business Overview
 Table 157. NovaBay Pharmaceuticals Vancomycin Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2020-2025)
 Table 158. NovaBay Pharmaceuticals Vancomycin Product
 Table 159. NovaBay Pharmaceuticals Recent Developments/Updates
 Table 160. NovoBiotic Pharmaceuticals Company Information
 Table 161. NovoBiotic Pharmaceuticals Description and Business Overview
 Table 162. NovoBiotic Pharmaceuticals Vancomycin Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2020-2025)
 Table 163. NovoBiotic Pharmaceuticals Vancomycin Product
 Table 164. NovoBiotic Pharmaceuticals Recent Developments/Updates
 Table 165. Oragenics Company Information
 Table 166. Oragenics Description and Business Overview
 Table 167. Oragenics Vancomycin Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2020-2025)
 Table 168. Oragenics Vancomycin Product
 Table 169. Oragenics Recent Developments/Updates
 Table 170. Sealife Pharma Company Information
 Table 171. Sealife Pharma Description and Business Overview
 Table 172. Sealife Pharma Vancomycin Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2020-2025)
 Table 173. Sealife Pharma Vancomycin Product
 Table 174. Sealife Pharma Recent Developments/Updates
 Table 175. Taiwan Zhengde Pharmaceutical Company Information
 Table 176. Taiwan Zhengde Pharmaceutical Description and Business Overview
 Table 177. Taiwan Zhengde Pharmaceutical Vancomycin Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2020-2025)
 Table 178. Taiwan Zhengde Pharmaceutical Vancomycin Product
 Table 179. Taiwan Zhengde Pharmaceutical Recent Developments/Updates
 Table 180. Zhejiang Pharmaceutical Company Information
 Table 181. Zhejiang Pharmaceutical Description and Business Overview
 Table 182. Zhejiang Pharmaceutical Vancomycin Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2020-2025)
 Table 183. Zhejiang Pharmaceutical Vancomycin Product
 Table 184. Zhejiang Pharmaceutical Recent Developments/Updates
 Table 185. Zhejiang Haizheng Pharmaceutical Company Information
 Table 186. Zhejiang Haizheng Pharmaceutical Description and Business Overview
 Table 187. Zhejiang Haizheng Pharmaceutical Vancomycin Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2020-2025)
 Table 188. Zhejiang Haizheng Pharmaceutical Vancomycin Product
 Table 189. Zhejiang Haizheng Pharmaceutical Recent Developments/Updates
 Table 190. North China Pharmaceutical Company Information
 Table 191. North China Pharmaceutical Description and Business Overview
 Table 192. North China Pharmaceutical Vancomycin Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2020-2025)
 Table 193. North China Pharmaceutical Vancomycin Product
 Table 194. North China Pharmaceutical Recent Developments/Updates
 Table 195. Shenwei Pharmaceutical Company Information
 Table 196. Shenwei Pharmaceutical Description and Business Overview
 Table 197. Shenwei Pharmaceutical Vancomycin Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2020-2025)
 Table 198. Shenwei Pharmaceutical Vancomycin Product
 Table 199. Shenwei Pharmaceutical Recent Developments/Updates
 Table 200. Key Raw Materials Lists
 Table 201. Raw Materials Key Suppliers Lists
 Table 202. Vancomycin Distributors List
 Table 203. Vancomycin Customers List
 Table 204. Vancomycin Market Trends
 Table 205. Vancomycin Market Drivers
 Table 206. Vancomycin Market Challenges
 Table 207. Vancomycin Market Restraints
 Table 208. Research Programs/Design for This Report
 Table 209. Key Data Information from Secondary Sources
 Table 210. Key Data Information from Primary Sources
 Table 211. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Vancomycin
 Figure 2. Global Vancomycin Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Vancomycin Market Share by Type: 2024 & 2031
 Figure 4. Daptomycin Product Picture
 Figure 5. Linezolid Product Picture
 Figure 6. Quinupristin Product Picture
 Figure 7. Ampicillin Product Picture
 Figure 8. Chloramphenicol Product Picture
 Figure 9. Others Product Picture
 Figure 10. Global Vancomycin Market Value by Application (2020-2031) & (US$ Million)
 Figure 11. Global Vancomycin Market Share by Application: 2024 & 2031
 Figure 12. Sepsis
 Figure 13. Lung Infection
 Figure 14. Skin Soft Tissue Infection
 Figure 15. Colitis & Intestinal Inflammation
 Figure 16. To Prevent Infection
 Figure 17. Global Vancomycin Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 18. Global Vancomycin Market Size (2020-2031) & (US$ Million)
 Figure 19. Global Vancomycin Sales (2020-2031) & (KG)
 Figure 20. Global Vancomycin Average Price (US$/G) & (2020-2031)
 Figure 21. Vancomycin Report Years Considered
 Figure 22. Vancomycin Sales Share by Manufacturers in 2024
 Figure 23. Global Vancomycin Revenue Share by Manufacturers in 2024
 Figure 24. Global 5 and 10 Largest Vancomycin Players: Market Share by Revenue in Vancomycin in 2024
 Figure 25. Vancomycin Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 26. Global Vancomycin Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 27. North America Vancomycin Sales Market Share by Country (2020-2031)
 Figure 28. North America Vancomycin Revenue Market Share by Country (2020-2031)
 Figure 29. U.S. Vancomycin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Canada Vancomycin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Europe Vancomycin Sales Market Share by Country (2020-2031)
 Figure 32. Europe Vancomycin Revenue Market Share by Country (2020-2031)
 Figure 33. Germany Vancomycin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. France Vancomycin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. U.K. Vancomycin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Italy Vancomycin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Russia Vancomycin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Asia Pacific Vancomycin Sales Market Share by Region (2020-2031)
 Figure 39. Asia Pacific Vancomycin Revenue Market Share by Region (2020-2031)
 Figure 40. China Vancomycin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Japan Vancomycin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. South Korea Vancomycin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. India Vancomycin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Australia Vancomycin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Taiwan Vancomycin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Indonesia Vancomycin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Thailand Vancomycin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Malaysia Vancomycin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Philippines Vancomycin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Latin America Vancomycin Sales Market Share by Country (2020-2031)
 Figure 51. Latin America Vancomycin Revenue Market Share by Country (2020-2031)
 Figure 52. Mexico Vancomycin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Brazil Vancomycin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Argentina Vancomycin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. Middle East and Africa Vancomycin Sales Market Share by Country (2020-2031)
 Figure 56. Middle East and Africa Vancomycin Revenue Market Share by Country (2020-2031)
 Figure 57. Turkey Vancomycin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 58. Saudi Arabia Vancomycin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 59. UAE Vancomycin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 60. Global Sales Market Share of Vancomycin by Type (2020-2031)
 Figure 61. Global Revenue Market Share of Vancomycin by Type (2020-2031)
 Figure 62. Global Vancomycin Price (US$/G) by Type (2020-2031)
 Figure 63. Global Sales Market Share of Vancomycin by Application (2020-2031)
 Figure 64. Global Revenue Market Share of Vancomycin by Application (2020-2031)
 Figure 65. Global Vancomycin Price (US$/G) by Application (2020-2031)
 Figure 66. Vancomycin Value Chain
 Figure 67. Channels of Distribution (Direct Vs Distribution)
 Figure 68. Bottom-up and Top-down Approaches for This Report
 Figure 69. Data Triangulation
 Figure 70. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Bioinformatics Barcelona

SIMILAR REPORTS